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AutoimmunityThe prevalence of autoimmune diseases has signiﬁcantly increased over the recent years. It has been
proposed that this epidemiological evidence could be in part attributable to environmental estrogens,
compounds that display estrogen-like activity and are ubiquitously present in the environment.
Environmental estrogens can be found in awide variety of foods: phytoestrogens occur in plants such as clover
and soy, while mycoestrogens are food contaminants produced by fungi. Meat, eggs and dairy products from
animals given exogenous hormones contain relatively high concentration of estrogens. Among xenoestrogens,
industrial estrogens are synthetic chemicals produced for speciﬁc purposes (pesticides, plastics, surfactants
and detergents) while metalloestrogens are found in heavy metals. Estrogens can be also administered
through medications (contraceptive pill, hormone replacement therapy, genistein, cimetidine, creams).
There is a considerable burden of evidence in vitro and in animal models that these compounds may exert
immunotoxic effects. However, to date there is no convincing data that exposure to environmental estrogens
can be regarded as a risk for human health. In particular, there is no consensus whether prolonged exposure
to relatively low concentrations of different estrogenic chemicals can affect the human immune system and
induce clinically evident diseases in real-life scenario. Moreover, the effects on human health of the synergistic
interactions between natural, medical, dietary and environmental estrogens have not been fully elucidated
yet. Here we provide an extensive review of the in vivo and in vitro effects of environmental estrogens
on the immune system, focusing on the evidences of association between exposure and autoimmune
disorders.
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Sex hormones display profound effects not only on the reproductive
system but also on other cell types. In particular, they may affect the
immune system by modulating cytokine production, their receptorgy, Istituto G. Pini, Piazza C.
ni).
rights reserved.expression and ultimately regulating the responses of different effector
cells [1, 2].
Such an effect can be displayed on physiological immune
responses against not only exogenous antigens but also self-
components. This represents the rationale for the interference of sex
hormones on autoimmunity and on its clinical manifestations [1, 2].
Autoimmune diseases are, in fact, a prototypical class of illness that
displays high female-to-male (F/M) ratios. Although the reason of
the F/M ratios in autoimmune diseases is still a matter of research,
there is evidence for the inﬂuence of estrogenic hormones. Moreover,
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activity and to comorbidities inﬂuencing also the clinical management
of the disease.
In addition to the endogenous source of estrogen (17β-estradiol,
E2), the immune system can be targeted by different chemical
molecules present in the environment and displaying an estrogen-
like activity, the so called environmental estrogens [3].
The real impact of both endogenous and environmental estrogens
on the immune system is still under investigation. The estrogens from
exogenous sources may display a synergic/additive effect with that of
endogenous molecules and theoretical may display sensitive effects
on the immune responses. Because of the predominance of females
in autoimmune diseases, it should also be taken into consideration
the role of estrogens of therapeutic sources, i.e., oral contraceptives
and hormone replacement therapy.
We will address the potential role of estrogens from exogenous
sources and in particular from the environment after a schematic
introduction of the potential effects of these hormonal molecules on
the immune system.
2. Role of estrogens in the immune responses
There is evidence that estrogens may affect several effector cells of
the immune system. Speciﬁc receptors for estrogens (ER) have been
found on the immune cells, supporting a direct effect. Two kinds of
estrogen receptors (ERs) have been identiﬁed in human beings, called
ER-α and ER-β. The same estrogen can produce different effects
depending on which receptor it binds and the ultimate effect of the
hormones is closely related to the receptor subtype present on a
given cell type. For example, increased expression of ER-β versus
ER-α in several inﬂammatory conditions may account for the
pro-inﬂammatory effect of estrogens [1, 2].
On the other hand, estrogens display different effects on several
effector cells of the immune system depending on their levels and
on the type of the target cells. For example, high levels, such as during
pregnancy, may inhibit pro-inﬂammatory cytokines (i.e. tumor
necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6) in monocytes and
dendritic cells (DCs), while anti-inﬂammatory cytokines (i.e. IL-10
and transforming growth factor (TGF)-β) are increased. A similar
inhibition of TNF-α with increase of IL-4, IL-10, interferon (IFN)-γ
and TGF-β is found in T cells . On the other hand, lower levels, as
during menopause, are associated with stimulation in TNF-α, IFN-γ
and TGF-β secretion by T cells and macrophages/DCs. Natural killer
(NK) cell activity is inhibited by high and stimulated by low levels.
This dichotomy of E2 at high versus low concentrations is not
observed for B cells, because antibody production is stimulated
throughout the concentration range [2].
As a whole these ﬁndings support a direct role of estrogens in
tuning the immune responses and underline how many variables
are involved in such a regulation. The complexity of this regulation
is also related to the presence of ERs on cells of both the innate and
the adaptive immunity.
3. Role of estrogens in autoimmunity
The key role of estrogens in autoimmunity is illuminated by the
example of systemic lupus erythematosus (SLE) [4, 5].
There are several indirect facts supporting a role for sex hormones
in SLE pathogenesis. For example, the incidence of SLE increases after
puberty and diminishes after menopause. The severity of the disease
itself varies with physiological modiﬁcations of the estrogen levels
such as during the menstrual cycle and with pregnancy. Both male
and female patients with SLE display higher quantities of estrogens and
lower levels of androgens in comparison with the normal population. A
chronic hyperestrogen state has been reported in women with SLE dueto an abnormal metabolism, with an increase in the production of
16-hydroxyestrone and estrol metabolites.
The abnormally high levels of E2, together with the low levels of
testosterone, dihydrotestosterone, DHEA and DHEA sulfate were
suggested not only to facilitate the disease start but also to be respon-
sible for the exacerbation of the lupus disease. Conversely, men with
androgen deﬁciency, such as in the Klinefelter's syndrome, display a
greater incidence of autoimmune diseases associated with the Th2
response (including SLE) than healthy men.
These clinical observations in humans are strongly supported by
experimental studies in SLE animal models. For example, the disease
predominates in both MRL/lpr and (NZB×NZW) F1 female mice, the
two prototype murine lupus models. The link is also supported by
gonadectomized murine lupus models, being ovariectomized female
(NZB×NZW) F1 mice less affected than castrated males. Consistently,
the administration of the estrogen antagonist increases survival and
normalizes immune parameters. Although, ER-α gene modulation
shows different (opposite) results in (NZB×NZW) F1 and MRL/lpr
mice, it is generally accepted that estrogen and ER-α play a key role
in the onset of the experimental lupus-like disease.
There is a clear evidence for an enhancing effect of estrogens on B
cells. In particular, E2 induces a polyclonal activation in vitro and is
associated with increased production of autoantibodies both in
patients and in lupus mice. Such a mechanism is likely to be crucial
in a prototype of an autoantibody-mediated autoimmune disease as
SLE.
Both androgens and estrogens have an impact on the Th1/Th2
balance. Estrogenspromote autoimmune diseaseswith a type 2 cytokine
proﬁle, like SLE,whereas androgenspromote autoimmune diseaseswith
a Th1 proﬁle. Th1 type diseases are improved when Th1 cytokines
decrease or when Th2 are rising (i.e. by increased estrogens, as in
pregnancy). Conversely, Th2 type diseases improve when Th2 are
diminished (by decreased estrogen, as in post-partum period) or when
type 1 response is stimulated.
So, sex hormones appear to modulate the effector cells of the
immune system and consequently the immune responses both by
interacting directly with their speciﬁc cell membrane receptors and
indirectly by affecting the production of solublemediators (cytokines)
eventually acting on the immune cells.
However, it should be stressed that sex hormones seem to be
secondary players rather than the triggermechanisms for autoimmunity.
In other words they can help to downregulate a process that is triggered
by other events and strongly sustained by a genetic background.
4. Environmental estrogens
Environmental estrogens are ubiquitously present, being found in
food, soil, air, water and household products. Therefore, environmental
exposure to estrogenic chemicals can occur via oral, aerosol, dermal and
subdermal routes.Many of these compounds can accumulate in adipose
tissues, being released from body fat during starvation. They could also
be passed on to the progeny during pregnancy and lactation.
Environmental estrogens can be of natural origin, being isolated
from plants (phytoestrogens) and fungal products from Fusarium sp
(mycoestrogens). Moreover, a number of synthetic chemicals have
estrogen-like activity, referred to as xenoestrogens. Chemically-
synthetized environmental estrogens can be found in plastics, deter-
gents, surfactants, pesticides and industrial chemicals. In addition, a
new class of environmental estrogens – the metalloestrogens – has
been identiﬁed. It should then bementioned that some pharmacological
compounds found in medications may also exert an estrogenic activity
[3].
Nowadays, environmental estrogens present a global distribution:
high levels of dichlorodiphenyl-trichloroethane (DDT) have been
found even in the arctic, remotely from industrialization [6, 7].
Considering their ubiquitous nature, it is clear that human beings as
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exposed to these compounds. The exposure to environmental estrogens
is believed to have increased over the years: while archiestrogens
(phytoestrogens andmycoestrogens) have beenpart of the environment
even before the existence of the human race, the use of synthetic
estrogens in manufacturing and farming has undergone a dramatic
spread in the 20th century.
Some of these chemicals resemble the structure of natural estrogens
(Fig. 1), while many others interfere with the action and production of
natural hormones. Although less potent than E2, these compounds have
been shown to bind to ER-α and ER-β; it has been proposed that they
could bind also to novel estrogen or non-estrogen receptors. Once
bound, environmental estrogens presumably induce translocation of
the receptor–ligand complex from the cytoplasm to the nucleus,
stimulating the synthesis of estrogen-regulated proteins. Moreover,
environmental estrogens could display their pharmacological effects
by antagonizing endogenous hormones, altering the pattern of
synthesis and metabolism of natural hormones and modifying
hormone receptor levels [8]. Most of these effects are reversible
once the exposure ceases, as seen in cases of occupational exposure to
estrogenic pesticides. In contrast, the consequences of developmental
exposure during organogenesis may result in irreversible deleterious
effects.
Concerns about environmental exposure to endocrine disruptors
have ﬁrst been raised in the 70s, when emerged that in utero exposure
to diethylstilbestrol (DES), a synthetic estrogen, was associated with
somatic effects in adulthood, including female genital abnormalities,
vaginal cancer, and male urogenital disorders. DES had been largely
used from1948 to 1971 in themanagement of conditions as threatened
abortions, pre-eclampsia, prior premature labor, prostatic and breast
cancer, pregnancy complications in diabetic women [9–11]. It is
estimated that 2 to 4.8 million human offspring were exposed to
DES [12].
Even if it is no longer used during pregnancy, it has been demon-
strated that exposure to DES could occur through consumption of
meat and milk products from animals that received DES as food
additive, while farmers handling DES presented occupational exposure
to the compound. Further, a link between prenatal DES exposure and
autoimmune disease has been suggested: women prenatally exposed
to DES appeared to have a higher incidence of rheumatic diseases2,3,7,8-tetrachlo
17β-estradiol
Bisphenol-A
Fig. 1. Similarities between the chemical structures[13, 14]. Moreover, mice given DES during the neonatal period have
an impaired immune system (particularly T cells), including atrophy
of the thymus, reduced proliferative response to T-cell mitogens,
diminished antigen-speciﬁc delayed-type hypersensitivity, graft-versus-
host reaction, cytotoxic response to mammary viruses, and NK cell
function [15].
Therefore, concerns about possible effects of environmental
estrogens on the immune system have been raised. Few peculiar
characteristics make it particularly vulnerable to chemical insults.
First, the evidence that immune system develops rather late in life:
the thymus development continues at least until puberty. Moreover,
bone marrow-derived immune components are continuously being
renewed. Lastly, immune surveillance and responses to pathogens
demand a delicate tuning [16].
Chemicals can adverse the immune system in several ways, not
only by inducing immunosuppression but also by enhancing immune
and inﬂammatory responses. It has been proposed that environmental
estrogens may mediate immunologic changes directly by binding to
immune cells or indirectly by acting on several other tissues,modulating
cytokine production. The molecular mechanisms responsible for
immunotoxicity have been progressively elucidated: carbamates and
organophosphate insecticides inhibit acetylcholinesterase, a serine
hydrolase which plays a pivotal role in several immune functions.
Conversely, some organophosphorous compounds are thought to
derive their immunotoxicity from induction of oxidative stress, while
modulation of nuclear factor-κB (NF-κB) activation could explain
some of the immunotoxic effects described for dithiocarbamates and
propanil [17, 18].
4.1. Effects of environmental estrogens on the immune system
Hereafter we provide an extensive review of the evidences of the
effects of environmental estrogens on immunity in vitro, in animal
models and in humans.
Environmental estrogens can be found in a wide range of foods;
their immunotoxic effects are summarized in Table 1.
Phytoestrogens are naturally-occurring plant compounds structurally
and functionally similar to mammalian estrogens, and are widely
believed to provide an array of beneﬁcial effects: being antioxidants,
they exert preventive and therapeutic actions in carcinogenesis,odibenzo-p-dioxin
genistein
daidzein
of 17β-estradiol and environmental estrogens.
Table 1
Immunomodulatory effects in vitro and in animal models of environmental estrogens found in food.
Food Compound Effects in animal models In vitro effects
Soybeans
Clover
Whole grains Fruits
Vegetables
Daidzein – Mice: increased phagocytic response of peritoneal
macrophages and thymus weight [21]
– Macrophages: reduced activation of STAT-1 [22]
– DCs: reduced expression of CD40, CD80, CD86, class II HLA
molecules; reduced synthesis of IL-12p40, IL-6, TNF-α, [23]
Genistein – Mice: reduced thymic weight, numbers of peripheral
CD4+ and CD8+ cells, suppressed antigen-speciﬁc
immune response [89]
– Decreased lymphocyte proliferation response
induced by mitogen or alloantigen [89]
– Mice: improvement of collagen-induced arthritis [91]
– NKs: reduced RANTES and MIP-1 production [92]
– Mice: decreased IFN-γ production [90]
– Block of the progression of IgG-R to lysosomes [92]
– Pulmonary endothelial cells: increased eNOS activation [93]
Corn
Grains
Zearalenone – Suine: decreased TNF-α, IL-8 and Ig levels [24] – Increased lipid peroxidation in lymphocyte membranes [25]
– Increased IL-2 and IL-5 secretion by EL4 thymoma cells [26]
– Reduced human and rat peripheral blood lymphocyte
proliferation [27]
Pork meat
Poultry meat Cattle meat
Eggs
Dairy products
17β-estradiol No data No data
DCs: Dendritic cells; IL: interleukin; TNF: tumor necrosis factor; IFN: interferon; NKs: Natural Killer cells; MIP: macrophage inﬂammatory protein; IgG-R: immunoglobulin G Recep-
tor; Ig: immunoglobulin.
A496 C. Chighizola, P.L. Meroni / Autoimmunity Reviews 11 (2012) A493–A501atherosclerosis and osteoporosis. Lignans, one of phytoestrogen major
classes, are components of plant walls, being found in many ﬁber-rich
foods such as berries, seeds (particularly ﬂaxseeds), grain, nuts and
fruit. Most phytoestrogens, however, are phenolic compounds belonging
to the isoﬂavone class.
Isoﬂavones are present in berries, wine, grains and nuts, being
however most abundant in soybeans and other legumes. It is worthy
to underline that soy is found in up to 60% of processed food, being a
food additive and a meat substitute. Genistein and daidzein are the
two most well characterized isoﬂavones [19, 20].
Daidzein has been reported to exert a stimulatory effect on non-
speciﬁc immunity in mice: at high dose, it increased the phagocytic
response of peritoneal macrophages and thymus weight, in a dose‐
dependent manner. Augmentation of spleen immunoglobulin (Ig)
M‐producing cells against sheep red blood cells (SRBC) demonstrated
an activation of humoral immunity [21].
In vitro, daidzein has been demonstrated to increase theproliferation
of splenocytes and the activity of peritoneal macrophages, NK and
cytotoxic T cells. In macrophages, it has also been shown to inhibit the
activation of the signal transducer and activator of transcription
(STAT)-1, an important transcription factor in the production of nitric
oxide (NO) [22]. In DCs, daidzein signiﬁcantly and dose-dependently
inhibited the expression levels of maturation-associated cell surface
markers (CD40, CD80, CD86) and class II major histocompatibility
complexmolecules. Daidzein also suppressedpro-inﬂammatory cytokine
production such as IL-12p40, IL-6 and TNF-α, whereas didn't affect IL-10
and IL-1β expression. Furthermore, daidzein enhanced endocytosis and
inhibited the allo-stimulatory ability of LPS-stimulated DCs on T cells,
suggesting that daidzein treatment can inhibit the functional maturation
of DCs [23].
Zearalenone is the best characterized mycoestrogen, a resorcyclic
acid lactone produced by several Fusarium species. It is a fungal
contaminants of corn and grains. Recently, the effects of zearalenone
on the suine immune system have been reported: it induced a decrease
in Ig levels, TNF-α and IL-8 synthesis [24]. In vitro, zearalenone has
been shown to cause pronounced abnormalities in lymphocyte
membranes through increased lipid peroxidation [25] and to augment
the ability of EL4 thymoma cells to secrete IL-2 and IL-5 [26]. Moreover,
zearalenone induced a dose-dependent reduction of human and rat
peripheral blood lymphocyte proliferation [27].
Finally, it should be remembered that animal-derived foods possibly
contain estrogens: these could be of endogenous origin, contaminants
in animal feed or artiﬁcially administered. Application of estrogens in
anabolic preparations to increase live weight gain is indeed licensed in
several countries except the European Union. Estrogens are artiﬁciallyadministered also to dairy animals to increase milk production.
Hormones are generally introduced into animals by an ear implant,
inducing a 7-to-20 fold increase in hormone levels. Estrogens may
therefore be constituents of eggs, dairy products and meat of pork,
poultry and cattle. Their consumption might affect human circulating
steroid hormone concentrations either directly or by inﬂuencing
indirectly endogenous hormonal production through their cholesterol
components. At present, the potential relevance of animal estrogens
on human health is still obscure [28].
Xenoestrogens are synthetic chemical contaminants in the
environment that represent a structurally diverse group of hydrocarbons
with an estrogen-like activity. Many xenoestrogens contain one or two
aromatic rings and some xenoestrogens are chlorinated being negatively
charged.
Estrogen-mimicking chemicals can be found in many household
products, as plastics, detergents and surfactants.
Bisphenol-A is a component of resin used in dentistry and in the
plastic industry. A recently published paper reviewed more than
5000 safety-related studies, concluding that exposure to bisphenol-A
represents no noteworthy risk to the health of the human population
[29]. However, in vitro data suggested that bisphenol-A could display
some effects on the immune system: it has been shown to inhibit the
synthesis of monocyte-chemoattractant protein (MCP) –1 in a tumor
cell line, with a potency three times greater than that of E2 [30].
Moreover, bisphenol-A inhibited adherence ofmacrophages, an essential
pre-requisite for their phagocytic function [31].
Octylphenol is a surfactant additive widely used in themanufacture
of a variety of detergents and plastic products. Reported to exhibit
weak estrogenic activity, octylphenol promoted lymphocyte cell
death, through a mechanism mediated by ERs [32, 33]. Moreover,
octylphenol blocked the estrogen-induced activation of IL-1β gene
activation in a monocytic cell line [34].
Several pesticides have been shown to exert an estrogenic activity
(Table 2). The term “pesticide” deﬁnes a variety of agents used to kill
living organisms. They include insecticides, herbicides and fungicides.
It is estimated that annually approximately 7000 metric tons (mt) of
herbicides, 8000 mt of insecticides and 9000 mt of fungicides are
used worldwide.
DDT is a chlorinated insecticide; being highly lipid-soluble, it is
stored in lipid-rich tissues, as liver, brain and adipose tissue. DDT
was ﬁrst synthesized in 1874, but its pesticide properties were
discovered in 1939. It was used in wartime to control typhus and
malaria, and put into agricultural use in the U.S. in 1945, to be banned
from in 1972. However, it was still manufactured and then sent to
other countries, often as part of U.S. agricultural aid. The diet is the
Table 2
Immunomodulatory effects of estrogenic pesticides in vitro, in vivo in humans and in animal models.
Class Compound In vivo effects in humans Effects in animal models In vitro effects
Insecticides DDT – Prenatal exposure: increased risk of otitis media
[35]
– (NZB X NZW) F1 mice: increased incidence of
albuminuria, reduced uterine weight [41]
– Diminished neutrophil
functions and mitogen-induced
lymphocyte proliferation
response [36]
– Postnatal exposure: increased upper respiratory
tract infections [36]
– Increased rate of mast-cell de-
granulation [39, 40]
– Immune response to diphtheria vaccine not
impaired [37]
– Increased rate of asthma in children [38]
Methoxychlor – Male rats: increased splenic weight, decreased
thymus weight and Abs forming cells; female rats:
thymic atrophy [3]
– (NZB X SWR:J) F1 mice: splenomegaly, increased
splenocyte numbers, expression of CD95 and CD54
on lymphocytes [3]
– Female rats: decreased bone marrow CFU-GM,
CFU-M AND IL-3 [45]
Chlordane – Increased incidence of sinusitis, bronchitis,
migraine [42]
– Increased frequency of ANA [43, 44], anti-dsDNA
and anti-smooth muscle Abs [43]
– Increased frequency of cortical thymocytes,
decreased T suppressors [43]
Herbicides Hexachlorbenzene – Increased serum IgM and IgG levels [46] –Mice: depressed production of antibody-forming
cells, serum IgG, IgM, IgA levels, delayed hypersensi-
tivity, lymphocyte responses, TandB-cell functions [50]
– Increased autoimmune conditions [47]
– Lewis rats: increased serum IgG levels and Abs
positivity, lymphoid organ weights, T- and B-cell
speciﬁc mitogen blastogenesis [50]
– Decreased neutrophil functions [48]
– Decreased IFN-γ production [49]
Fungicides Pentachlorphenol – Decreased lymphocyte proliferative response to
mitogens [57,58]
– Decreased NK cell activity [59]
– Decreased lymphocyte proliferative response to
mitogens, blood monocytes, serum IL-8, CD4/CD8
ratio, CD4 cells [46]
– Decreased lymphocyte proliferative response to
mitogens, serum Ig [55]
– Increased anti-smooth muscle Abs, CD10 cells,
NK cell activity [55]
– Increased prevalence of low-grade infections or
inﬂammations of the skin, subcutaneous tissues,
eyes and upper respiratory tract mucosa [56]
– Decreased T cells, CD8 cells, NK cells,
lymphocyte proliferative response to mitogens
[57]
Nematocides Aldicarb – Increased ANA positivity [51]
– Decreased CD4/CD8 ratio [51]
DDT: dichlorodiphenyl-trichloroethane; Abs: antibodies; ANA: anti-nuclear antibodies, anti-dsDNA: anti-double strand DNA antibodies, IL: interleukin; Ig: immunoglobulin; IFN:
interferon; NK: natural killer.
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comes from meat, poultry, dairy products and ﬁsh. DDE, DDT's main
metabolite, is one of the most ubiquitous toxins in foods.
Prenatal exposure to DDT increases the risk of otitis media [35];
post-natal exposure to DDT has been linked to impairment of the
upper respiratory tract immunity as evidenced by increased upper
respiratory tract infections. It has been demonstrated that DDT
diminished neutrophil functions and reduced mitogen-induced
lymphocyte proliferation response [36]. On the other hand, a study
enrolling children fromBrazil exposed to DDT showed that the immune
response to diptheria vaccine was not impaired [37]. Prenatal DDE
exposure increases also the rate of asthma in children (relative risk of
2.6) [38]; in vitro studies showed that DDT induces an increase in the
rate of mast-cell degranulation therefore augmenting the risk of allergy
[39, 40]. In (NZB×NZW) F1 lupus prone mice, DDT exposure markedly
increased the incidence of albuminuria, reduced uterine weight but had
no measured effects on immunity or mortality [41].
Methoxychlor is a synthetic organochlorine used as an insecticide;
it was intended to be a replacement for DDT, but has since been
banned based on its acute toxicity, bioaccumulation and endocrine
disruption activity. It has been demonstrated that male rats exposed
to methoxychlor during perinatal and prepubertal life had decreased
thymus weights and antibody forming cells with an increase in splenicweight. Conversely, the only immunological change of note in females
was thymic atrophy when exposed to the higher dose of methoxychlor.
The reported differences between genders suggest that endogenous sex
hormonesmaymodify the response to environmental chemicals. Lupus-
prone (NZB×SWR:J) F1mice receivingmethoxychlor had splenomegaly,
increased splenocyte cell numbers and increased expression of CD95 and
CD54 molecules on lymphocytes [3].
Chlordane is an organochlorine insecticide, whose effects in humans
have been investigated by few studies. In a non-random study involving
individuals concerned about exposure to chlordane, an increased inci-
dence of sinusitis, bronchitis and migraines was reported in exposed
subjects [42]. In another study, 27 patients exposed to chlordane
reportedmultiple immune impairments compared to controls: increased
frequency of cortical thymocytes with decreased T-suppressors. Sera of
chlordane-exposed individuals also had an increased frequency of auto-
antibodies against nuclear (ANA), DNA and smoothmuscle antigens [43].
The increased incidence of ANA has been conﬁrmed by an epidemiolog-
ical study conducted in a rural population exposed to agricultural chemi-
cals (including chlordane, dieldrin, heptachlor, lindane) [44]. Chlordane
has been shown to display immunosuppressive effects in prenatal ex-
posed mice: females, but not males, had a decrease in the numbers of
bone marrow colony forming units-granulocyte/macrophage (CFU-
GM), CFU-IL-3, and CFU-macrophage (CFU-M) [45].
A498 C. Chighizola, P.L. Meroni / Autoimmunity Reviews 11 (2012) A493–A501Hexachlorbenzene (HCB) was commonly used as a pesticide,
herbicide and fungicide. Although its production and use have ceased
in many countries, the compound is still generated inadvertently, as a
byproduct in the manufacturer of various chlorinated chemicals. In a
study in workers occupationally exposed to HCB, increased serum
IgM and IgG levels were observed, whereas serum IgA levels were
normal [46]. From 1955 to 1959, approximately 3000–5000 people in
southeastern Turkey ingested HCB-treated seed grain: in follow-up
studies autoimmune conditions such as dermatologic abnormalities,
neurologic symptoms, enlarged thyroid and hand arthritis still persisted
25–30 years after the poisoning incident [47]. Respiratory burst and
chemotaxis of neutrophils from 51 workers exposed to HCB were
signiﬁcantly reduced as compared to controls [48], while in 146 patients
with occupational exposure to HCB, a strong negative association
between HCB and IFN-γ blood levels was reported, suggesting that
HCB could have a signiﬁcant impact on Th1 lymphocytes [49].
In animal models, the effects of HCB on the immune system are
species-dependent. Humoral and cell-mediated immune responses
in adultmice are both affected by HCB. In these animals, it signiﬁcantly
depressed the production of antibody-forming cells, serum Ig levels
(IgG, IgM and IgA), delayed type hypersensitivity, mixed lymphocyte
responses, T- and B-cell functions. On the other hand, rats exposed
to HCB presented a marked increase in lymphoid organ weights, T-
and B-cell speciﬁc mitogen blastogenesis and antibody response. In
particular, in Lewis rats, this chemical has been shown to stimulate
the immune system, as evidenced by an increase in the expression of
serum IgM, autoantibody positivity and in the number of intraepithelial
T cells [50].
Aldicarb is a nematocide widely used in agriculture. An epidemio-
logical study showed an increased incidence of positivity for ANA in a
rural population exposed to aldicarb. Moreover, the chronic exposure
of aldicarb via contaminated ground water has been associated with a
decreased CD4/CD8 ratio [51].
Pentachlorophenol (PCP) is an organochlorine compound. First
produced in the 1930s, it has been extensively used as a biocide in
ﬁshery, agriculture and industry. Inmany lakes of China, a large quantity
of PCP has been sprayed to prevent a schistosomiasis epidemic.
Although PCP had been banned for further use in 1990, its persistence
resulted in a long-lasting contamination of aquatic environment [52].
PCP displays an anti-estrogenic effect, reducing the estrogenicity of E2
by competitive binding to the estrogen receptors [53]. The toxicological
and immune effects of PCP on the immune systemhad been evaluated in
32 subjectswhohadprolonged exposure to PCP in awood factory and in
37 controls. The ﬁndings were not suggestive of any PCP-dependent im-
mune deﬁciency: there was no difference in CD3+, CD4+, and CD8+
lymphocyte subsets and in the proliferative response of peripheral
blood mononuclear cells to mitogens between patients and controls
[54]. Conversely, another study on38 subjectswith exposure to PCP pro-
vided conﬂicting results: exposed individuals had activated T-cells, au-
toimmunity, functional immunosuppression with decreased serum Ig
levels and B-cell dysregulation. Autoimmunity was evidenced by eleva-
tion of TA1 phenotype frequencies and a 21% incidence of anti-smooth
muscle antibody [55]. In another study enrolling 46 subjects with occu-
pational exposure to PCP, an increased prevalence of low-grade infec-
tions and inﬂammations of the skin, subcutaneous tissues, eyes and
upper respiratory tract mucosa has been reported. Strong to moderate
statistical associations were observed between PCP exposure and in-
creased immature leucocytes and basophils, raised plasma cholinester-
ase, alkaline phosphatase, IgG and uric acid, with decreased serum
calcium [56]. Several studies have reported an association between di-
minished lymphocyte proliferative response to mitogens and exposure
to PCP [46, 55, 57, 58]. A reduced NK cell activity has been linked to
PCP exposure in vitro [59].
Although several pesticides (chlordane, HCB, PCP, chlorpyrifos [43,
45, 55, 60]) have been associated with an increased prevalence of
ANA, few studies have evaluated the possible role of pesticides asrisk factors for autoimmune diseases. In the Carolina Lupus Study,
investigators found a trend for an association between increased
prevalence of high-titer ANA and the summation of exposures to
pesticides, silica, mercury, sunlight and use of hair dyes [61]. Farming
and agricultural pesticide use have been associated with SLE, with an
odds ratio (OR) of 7.4 [62].
A weak association has also been reported for organochlorine
pesticides exposure and rheumatoid arthritis (RA, Relative Risk 2)
[63, 64]. In the Women's Health Initiative Observational Study
(76.861 postmenopausal women enrolled, aged 50–79 years), personal
use of insecticides was associated with an increased risk of RA and SLE.
Risk was also associatedwith long-term insecticide application (Hazard
Ratio (HR) 1.85) and frequent application among women with a farm
history (HR 2.73). Although these ﬁndings require replication in other
populations, they support a role for environmental pesticide exposure
in the development of autoimmune rheumatic diseases [65].
Estrogenic chemicals are often produced in many industries: these
compounds are referred to as industrial estrogens.
Polychlorinated biphenyls (PCBs) are a group of 209 different
chemicals which share a common structure but vary in the number
of attached chlorine atoms. These compounds were once used as
insulators in the electrical industry and are now banned in the U.S.,
Northern Europe and other countries.
Exposure to PCBs has been linked to RA: in a 2007 cross-sectional
study, serum concentration of PCBs was positively associated with a
self-reported diagnosis of RA (OR 2.2) [63]. Concerns of immune
alterations in PCB-exposed humans have also been raised: in a study
in Dutch children, PCB levels were tied to an increased prevalence of
ear infections and chickenpox with lowered immune system function
[66]. These ﬁndings have been conﬁrmed in the Yusho and Yu-Cheng
populations that experienced the highest levels of PCB exposure and
least complex exposure mixture. Moreover, serum IgA, IgM and
monocyte countswere decreased in theYusho andYu-Chengpopulations
[67]. Substantial evidence of the immunotoxicity of PCBs in research
animals lends strong support to the human data. Particularly relevant
ﬁndings in animals include reduced antibody responses and
T-lymphocyte levels, which are similar to changes observed in some of
the human populations. The antibody response to SRBC antigens is the
immune parameter most commonly and consistently shown to be
affected by PCBs in animals: reduced responses have been demonstrated
in most tested species, including adult and infant monkeys, which are
sensitive to chronic low PCB doses. Studies in rats, mice, guinea pigs,
and rabbits showed that intermediate-duration exposures to relatively
high doses of commercial PCB mixtures caused morphological and
functional alterations in the immune system: thymic and splenic atrophy,
increased susceptibility to infections, reduced skin reactivity to tuberculin
and increased proliferation of splenic lymphocytes in response to
mitogenic stimulation [68].
However, a 2003 critical synopsis of published data concluded that
there is no conclusive evidence of adverse health effects of PCBs at
concentrations encountered with human exposures [69].
2,3,7,8-tetrachloodibenzo-p-dioxin (TCDD) is the most potent among
the polychlorinated dibenzo-p-dioxins (in short but inaccurately also
called dioxin). It is formed as an unintentional by-product of incomplete
combustion, being released to the environment during the combustion
of fossil fuels and wood, and during the incineration of municipal and
industrial wastes. It is also a contaminant in Agent Orange, a herbicide
used in the VietnamWar [70].
The actions of TCDD and dioxin-like chemicals are mediated by
the aryl hydrocarbon receptor (AhR), a basic helix–loop–helix
transcription factor. Following ligand binding, the receptor–ligand
complex is translocated to the nucleus via the AhR nuclear translocator,
resulting in transcriptional activation. Target genes include cytochrome
P-450 and genes involved in cellular growth, differentiation and
inﬂammation [71]. TCDD is not mutagenic and not directly genotoxic:
it promotes the carcinogenicity initiated by other compounds. However,
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proposed mechanisms is oxidative stress and the subsequent oxygen
damage to DNA [72]. TCDD has also been shown to exert an anti-
estrogenic activity in the presence of estrogens, and estrogenic property
in the absence of estrogen [73].
The industrial accident that occurred in the area of Seveso (Italy)
on July 10, 1976 exposed a large residential population to substantial
amounts of TCDD. In the immediate aftermath, typical effects of exposure
to polychlorinatedhydrocarbons such as chloracnewere observedmainly
in children [74], an excess risk of lymphatic and hematopoietic tissue
neoplasms in the most exposed zones was reported [73].
Two cross-sectional studies suggest enhanced autoimmunity in
TCDD-exposed individuals: in a Vietnam and in a UK study, TCDD
exposure was associated with an increased positivity of ANA, concen-
tration of circulating immune complexes and lymphocytes [75, 76],
while a larger study in a German pesticide-producing factory reported
no correlation between dioxin concentration in blood lipids and auto-
antibody levels [77]. Twomore recent reports also failed to demonstrate
any induction of ANA in Japanese subjects intoxicated with TCDD [78]
and in Koreans veterans exposed to Agent Orange [79]. A 2004 study
showed that secondary immune responses to inﬂuenza viral pathogens
were likely to be inﬂuenced by TCDD exposures occurring prior to or at
the time of primary infections, as measured by virus-speciﬁc Ig levels,
while secondary responses were only temporarily suppressed. It is not
clear whether or not this immune alteration results in increased clinical
susceptibility to viral infections [80]. Current available data from animal
models suggest that TCDD exposure increases postnatal autoimmune
responses.
In (SWR×NZB) F1mice, resistant maleswere rendered susceptible
to lupus by E2 or TCDD treatment [81]. Moreover, prenatal exposure to
TCDD has been shown to cause selective enhancement of postnatal
immune responses, causing an autoreactive immune phenotype in
adult non-autoimmune mice and exacerbating autoimmune nephritis
in adult autoimmune SNF1 animals. Indeed, TCDD crosses the placenta
and alters normal development of central tolerance in the thymus and
normal prenatal thymocyte maturation, T-cell receptor and thymic
major histocompatability complex class II molecule expression [82].
Metalloestrogens include the heavymetals andmetalloids cadmium,
aluminum, antimony, arsenite, barium, cobalt, copper, chromium, lead,
mercury, nickel, nitrite, selenite, tin, uranium and vanadate.
Cadmium is widely used in industry, principally in galvanizing and
electroplating, in batteries, in electrical conductors, in the manufacture
of alloys, pigments, plastics and in the stabilization of phosphate
fertilizers. As a byproduct of smelters, cadmium is a prevalent environ-
mental contaminant. In the general population, exposure to cadmium
occurs primarily through dietary sources, cigarette smoking and, to a
lesser degree, drinking water. Similar to E2, cadmium induces cellular
proliferation, increases the transcription and expression of estrogen
regulated genes in human breast cancer cells [83, 84]. The effects of
the metal are mediated not only by the ERα genomic pathway but
also by nongenomic ERα pathways through ERK1/2 and Akt [85].
Early studies in Sprague–Dawley rats showed that exposure to cadmium
via drinkingwater caused immune-complex nephritis [86] and induced
production of antibodies against two components of the glomerular
basement membrane. After cadmium exposure, a signiﬁcant induction
of ANA was observed in ICR but not Balb/c mice, while exposing male
MRL lpr/lprmice to cadmiumaccelerated the age-dependent production
of anti-DNA antibodies [87].
It is important to bear in mind that also active compounds found
in some medications can exert, beside the main pharmacological
activity, estrogenic properties.
Genistein, now used as chemotherapic agent, had been isolated
from Genista tinctoria in 1899; it has been chemically synthetized in
1928. Genistein is a phytoestrogen that can be found in broad
beans, soy, coffee and psoralea. It inhibits the tyrosine-kinase protein
of the enzyme DNA topoisomerase type II [88]. Nowadays genistein isused as antineoplastic agent: it has been shown to stop G2 phase of
cellular cycle. In animal models, genistein induced dose-dependent
reduction in thymic weight, reduced the number of peripheral
CD4+ and CD8+ cells, suppressed antigen-speciﬁc immune response
[89] and decreased levels of IFN-γ protein [90]. Due to its unique effect
on the immune system, genistein has been used in the treatment of
collagen-induced arthritis, an animal model for RA: mice receiving
genistein prior to immunization with collagen showed less frequent
and less severe arthritis than controls [91]. The in vivo ﬁndings have
been conﬁrmed by in vitro experiments: genistein inhibited lympho-
cyte proliferation response induced by mitogen or alloantigen [89].
In NK cells stimulated with antibodies against CD43, it has been
shown to inhibit the secretion of chemokines as RANTES and macro-
phage inﬂammatory protein (MIP)-1. Genistein also blocked the
progression of internalized high-afﬁnity receptor for IgG to lysosomes.
Moreover, it has been shown to reverse in vitro the loss of T-cell
signaling components at post-menopausal estrogen levels, with no
signiﬁcant effect at pre-menopausal estrogen levels [92]. In broiler
pulmonary arterial endothelial cells genistein stimulated a rapid
phosphorylation of eNOS activating the eNOS/NO axis; the activation
of eNOS was not mediated through estrogen receptors or tyrosine
kinase inhibition, but via a phosphatidylinositol 3-kinase (PI3K)/Akt-
dependent signaling pathway, as the eNOS activity and related NO
release were largely abolished by pharmacological inhibitors of PI3K
or Akt [93].
Cimetidine is a histamine H2-receptor antagonist; it has been
shown to interfere with the metabolism of estrogens. It enhances
estrogen activity by decreasing the 2-hydroxylation of E2 resulting
in an increase in the serum estradiol concentration [94].
4-methylbenzylidene camphor is an organic camphor derivative
with a weak estrogenic activity. It is used in the cosmetic industry
for its ability to protect the skin against UV, speciﬁcally UV B radiation.
Therefore, it is widely used in sunscreen lotions and other skincare
products [95].
Parabens are a class of chemicals widely used as preservatives in
the cosmetic and pharmaceutical industries. They can be found in
shampoos, commercial moisturizers, shaving gels, personal lubricants,
topical/parenteral pharmaceuticals, spray tanning solution, makeup
and toothpaste. In an in vivo study, the effect of butylparaben was
100,000 times weaker than that of E2, and was only observed at a
dose approximately 25,000 times higher than the concentration
usually found in commercial products. The in vivo estrogenic activity
of parabens has also been found to be three orders of magnitude
reduced compared to in vitro activity [96].
Lastly, it should be remembered that estrogens from human urine
enter the rivers from sewage; moreover, women receiving estrogens
for medical purposes (contraceptive pill, hormone replacement
therapy) display much higher urinary E2 concentrations.
5. Conclusions
Epidemiological evidence from Western countries indicates that
the prevalence of autoimmune diseases is strongly increasing, being
not merely attributable to improved diagnostics alone. Some authors
have therefore postulated that this could be, at least, partially attributable
to new or modiﬁed patterns of exposure to chemicals, including
environmental estrogens.
However, despite the immunotoxic effects generated under
experimental conditions, there is no convincing evidence that exposure
to environmental estrogens can be regarded as a risk for human health.
In particular, there is no data about the effects on human health of the
synergistic interactions between natural, medical, dietary and environ-
mental estrogens.
Therefore, the main issue is whether prolonged exposure to
relatively low concentrations of different chemicals showing immuno-
toxicity in experimental models can affect the human immune system
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effects on the human immune system are adaptive or if they are early
signs leading to clinically evident diseases.
These critical questionswill receive an answer only fromprospective,
controlled epidemiological studies with rigorous exposure assessment
in order to generate reliable exposure-response data. Immunotoxicity
studies in humans should focus on those compounds for which there is
convincing laboratory evidence for an effect on the immune system.
These studies should be performed in large cohorts: it is possible that
environmental estrogens may affect only certain subsets of the popula-
tionwith appropriate contributing factors, as a susceptible genetic back-
ground.Moreover, the studies should be long-term: the consequences of
immune alterations by environmental estrogens may not be clinically
apparent immediately after exposure.
There are a number of factors whose role should be critically
addressed when establishing the effects of environmental estrogens
on autoimmunity. First of all, developmental and senescent ages,
both periods characterized by sub-optimal immune competence,
may be more vulnerable to the effects of environmental estrogens on
the immune system. Gender could also affect sensitivity to estrogenic
chemicals: in animal models, male and female mice had different
responses to estrogen after exposure to chlordane and methoxychlor.
Studies in relevant animal models may offer more information at a
mechanistic level in particular.
It must be taken into account that in real-life scenario exposure to
multiple chemicals may occur, making it difﬁcult to assess the effects
of each compound.
Another critical issue is that most of the toxic effects exerted by
chemicals are characterized by the presence of a threshold, under
which no effect is anticipated. At this regard, it is also important to
consider that the immune system also possesses functional reserve
and redundancy in response to xenobiotics.
Moreover, it is likely that immune effects may vary depending on
the dose: estrogens display immunostimulant or immunodepressive
effects depending on the concentration. Also the duration of exposure
may affect the response of immune cells, being acute exposure more
critical for cellular balance.
In conclusion, the future challengewill be to unequivocally establish
whether environmental estrogens may contribute to the increasing
burden of immuno-related diseases.References
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